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The perivascular niche is a complex microenvironment containing mesenchymal stem cells (MSCs), 
among other perivascular cells, as well as temporally organized biochemical and biophysical gradients. 
Due to a lack of conclusive phenotypic markers, MSCs’ identity, heterogeneity and function within their 
native niche remain poorly understood. The in vitro reconstruction of an artificial three-dimensional (3D) 10 
perivascular niche would offer a powerful alternative to study MSC behavior under more defined 
conditions. To this end, we here present a poly(ethylene glycol)-based in vitro model that begins to mimic 
the spatiotemporally controlled presentation of biological cues within the in vivo perivascular niche, 
namely a stably localized platelet-derived growth factor B (PDGF-BB) gradient. We show that 3D-
encapsulated MSCs respond to soluble PDGF-BB by proliferation, spreading, and migration in a dose-15 
dependent manner. In contrast, the exposure of MSCs to 3D matrix-tethered PDGF-BB gradients resulted 
in locally restricted morphogenetic responses, much as would be expected in a native perivascular niche. 
Thus, the herein presented artificial perivascular niche model provides an important first step towards 
modeling the role of MSCs during tissue homeostasis and regeneration.
Introduction 20 
Mesenchymal stem cells (MSCs) have recently been described to 
reside in perivascular niches of several human tissues.1, 2 The de 
novo formation of these niches, which consist of an endothelium 
that is surrounded by perivascular cells, such as MSCs, relies on 
the spatiotemporal controlled presentation of biological cues.3 25 
Whereas metabolic demand, low oxygen tension, or healing 
wounds control the sprouting of endothelial cells by an elevated 
expression of vascular endothelial growth factor (VEGF),4 the 
mobilization of perivascular cells and their stable retention has 
been described to rely on factors released and presented from 30 
endothelial cells.5 One of these biological cues is platelet derived 
growth factor-B (PDGF-BB), which has been shown to promote 
chemotaxis, proliferation, and spreading of various perivascular 
cells.6 Its secretion at relatively large quantity by endothelial tip 
cells during vascular sprouting is required for perivascular cells 35 
to spread and proliferate along the vascular wall, initiating the 
indispensable vessel stabilization.7 Moreover, the distribution of 
endothelial cell secreted PDGF-BB is spatiotemporally controlled 
through its interaction with heparin sulfate proteoglycans (HSPG) 
of the extracellular matrix (ECM). The affinity binding of PDGF-40 
BB to ECM components results in an altered presentation of the 
molecule to MSCs, which will face matrix tethered growth 
factors rather than soluble factors. In addition, continuous ECM 
immobilization results in creation of a stable PDGF-BB gradient 
that descends from the vessel. This gradient is in turn sensed by 45 
perivascular cells and steers their localized assembly along the 
surface of the vessel (Fig. 1A).  
MSCs are operatively defined by their potential to differentiate 
into cells of the osteogenic, adipogenic, and chondrogenic lineage 
after in vitro expansion. However, the complexity of their in vivo 50 
localization in the perivascular niche and the lack of MSC-
specific markers hamper our further understanding of their 
identity, heterogeneity, and functional role in adult tissue 
homeostasis and regeneration.8 Therefore, there is great need for 
three dimensional (3D) in vitro models, which adequately 55 
recapitulate the in vivo arrangement of cells, ECM components 
and other biomolecules of the perivascular niche. Such models 
would allow for elucidation of biological processes that control 
the fate and localization of MSCs in the perivascular niche during 
vessel assembly, quiescence, or injury induced activation. 60 
Recently, the systematic deconstruction of stem cell niches and 
their reconstruction under defined conditions has been proposed 
as a mean to understand individual parameters of complex niche 
signaling networks.9 Indeed, great progress has been made 
towards the development of ECM-mimicking synthetic matrices, 65 
potentially allowing for the in vitro emulation of stem cell niches 
by the generation of 3D microenvironments.9-11 Such hydrogel 
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matrices, as they are based on biologically inert materials such as 
poly(ethylene glycol) (PEG), can be formed with defined 
stiffness and degradability. We have described synthetic, 
transglutaminase cross-linked hydrogels (TG-PEG hydrogels), 
which are enzymatically degradable and contain the cell adhesion 5 
site RGD12, 13 and at low stiffness allow 3D cell adhesion, 
spreading and migration.14 Their modular design, additionally to 
the flexible immobilization of engineered building blocks such as 
growth factors or enzymes,15 allowed the formation of structured 
hydrogels by locally controlling the enzymatic gel formation.16 10 
Of note, such PEG-based matrices, in contrast to biologically 
derived materials such as the widely used MatrigelTM or collagen, 
are highly defined and do not exert any biological response, 
allowing the studying of cell behavior on a blank canvas.17-19 
 15 
Here, in order to elucidate MSC behavior during PDGF-
controlled formation of the perivascular niche, we aimed at the 
creation of a 3D biomimetic model, which mimics the naturally 
occurring stable, matrix-immobilized PDGF-BB gradient, which 
is present in the perivascular niche. By placing MSCs within a 20 
3D-structured TG-PEG hydrogel,13 we describe an in vitro 
bottom-up approach for the recapitulation of physical as well as 
PDGF-presenting properties of the perivascular niche (Fig. 1B). 
In this model we first confirmed the specific ability of soluble 
PDGF-BB but not VEGF121 to activate MSCs, leading to 3D 25 
morphogenetic processes such as cell proliferation, spreading, 
and migration. Furthermore, we assessed the activity of matrix 
tethered PDGF on MSCs and finally we created stable 3D PDGF-
BB gradients, which resulted in spatiotemporal control of MSC 
spreading and motility, as was described during the naturally 30 
occurring investment of endothelium with perivascular cells. The 
herein described biomimetic niche model is a promising first step 
to study the role of MSCs during vascular morphogenesis, tissue 
healing and regeneration in vitro. 
Materials and Methods 35 
Cell culture 
Bone marrow aspirates were obtained from healthy donors 
(average age 28 y.o.) after informed consent during orthopaedic 
surgical procedures in accordance with the local ethical 
committee (University Hospital Basel; Prof. Dr. Kummer; 40 
approval data 26/03/2007 Ref Number 78/07). Cells were isolated 
as described previously20. Human bone marrow MSCs were 
cultured in minimal essential medium alpha (MEMalpha, Gibco 
Life Technologies, cat. no. 22571-020) supplemented with 10% 
(v/v) fetal calf serum (FCS, Gibco Life Technologies, cat. no. 45 
10500), 1% (v/v) penicillin/streptomycin solution (Gibco Life 
Technologies, cat. no. 15140-122) and 5 ng ml-1 FGF-2 
(Peprotech, cat. no. 100-18B). For experiments, MSCs were 
cultured in serum-free DMEM/F-12 + GlutaMAXTM (Gibco Life 
Technologies, cat. no. 31331-028) supplemented with 1% (v/v) 50 
penicillin/streptomycin solution. MSCs between passages 2 and 4 
were used for all of the experiments. 
 
Preparation of TG-PEG Hydrogels 
Matrix metalloproteinase (MMP)-sensitive TG-PEG hydrogels 55 
were prepared as described previously.21 In brief, eight-arm PEG 
precursors containing the pending factor XIIIa substrate peptides 
glutamine acceptor (n-PEG-Gln) or lysine donor with an 
additional MMP-sensitive linker (n-PEG-MMPsensitive-Lys) were 
mixed stoichiometrically (final dry mass content 1.5%) in Tris-60 
Buffer (50 mM Tris, pH 7.6) containing 50 mM calcium chloride. 
50 µM Gln-RGD peptide and indicated amounts of Gln-ZZ were 
added to the precursor solution prior to initiation of cross-linking 
by 10 U ml-1 thrombin-activated factor XIIIa and vigorous 
mixing. 65 
Fig. 1 Schematic representation of the perivascular niche. A) Native perivascular niche. The native perivascular niche is composed of endothelial cells, 
perivascular cells (pericytes and SMCs), MSCs and ECM matrix containing matrix associated and soluble cues. Endothelial cell derived PDGF-BB binds 
with high affinity to heparane sulfate proteoglycane components (HSPG) of the ECM and thereby form a stable localized gradient. B) Engineered 
perivascular niche. The engineered perivascular niche, analogous to its in vivo counterpart, consists of an artificial vessel, a proteolytically degradable 
matrix with integrin binding sites, and a stable gradient of PDGF-BB. The fate of MSCs can be evaluated within the defined, positional 
microenvironments. 
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 Microtissue formation 
For microtissue formation, indicated cell suspensions (final. conc. 
25’000 cells ml-1) were suspended in the respective medium for 
the experiment and supplemented with 0.2% (w/v) methyl 5 
cellulose (Sigma-Aldrich, cat. no. M0512). Droplets of 30 µl 
were placed in non-adhesive cell culture dishes (Greiner bio-one, 
cat. no. 633180) and cultured overnight as hanging drops. The 
resulting spheroids (approx. 750 cells) were harvested in cell 
culture medium and washed once with cell culture medium. 10 
 
Encapsulation of single cells and microtissues in TG-PEG 
hydrogels 
For encapsulating single dispersed cells or microtissues in TG-
PEG gels, cell or microtissue suspensions were diluted in the 15 
respective medium and added to the complete TG-PEG solution. 
To form disc shaped hydrogels of approximately 5 mm diameter, 
20 µl of this mixture were then sandwiched between sterile 
hydrophobic glass microscopy slides (obtained by treatment with 
SigmaCote, Sigmacote, Sigma-Aldrich, cat. no. SL2) separated 20 
by spacers (ca. 1 mm thickness) and clamped with binder clips. 
To prevent sedimentation of cells or microtissues, the forming 
matrices were slowly rotated at room temperature (RT) until the 
onset of gelation and then incubated for additional 30 min. at 
37°C. The hydrogels were thereafter released and transferred into 25 
a 24-well plate. Finally, the plates with the gels were incubated in 
500 µl of the respective medium at 37°C and 5% CO2 in a 
humidified atmosphere.  
 
Cell labeling 30 
After the experiments, the samples were fixed with 4% 
paraformaldehyde. After stopping the reaction with 0.1 M 
Glycine in PBS (phosphate buffered saline, pH 7.2), the samples 
were washed twice with PBS. Permeabilization was performed 
for 20 min at RT with 0.2% Triton X-100 (Sigma-Aldrich, cat. 35 
no. T-8787) in PBS followed by 2 washing steps with PBS. For 
F-actin staining, the samples were incubated over night at 4°C 
with rhodamine-labeled phalloidin (Life technologies, cat. no. 
R415). Afterwards, the samples were washed 3 times with PBS 
and stained for cell nuclei using Hoechst (1:1000, Life 40 
technologies, cat. no. H3570). Subsequently, the samples were 
washed again 3 times with PBS before analysis with either 
confocal laser scanning microscopy or fluorescent microscopy.  
 
Microtissue migration assay 45 
MSC microtissues were encapsulated in TG-PEG hydrogels (final 
conc.: approx. 250 microtissues ml-1) and cultured for 20 hours. 
The samples were fixed and stained for F-actin. Z-stack images 
of microtissues were acquired at 10 x magnification using a 
confocal microscope (Leica TCS SP5). Cell migration was 50 
quantified by an automated image analysis script written in 
MATLAB (R2013a, MathWorks Inc, USA) that measures the 
distance of stained pixels from the microtissue center. Data is 
displayed as histogram depicting the amount of pixels relative to 
the migration distance. Pixels with a distance larger than 100 µm 55 
from the spheroid center were considered in the statistical 
analysis. 
 
Single cell proliferation, spreading, and migration assays 
MSCs were embedded in TG-PEG hydrogels (final conc.: 0.5 x 60 
106 ml-1) and cultured for 5 days. For migration assays, three 
random positions were selected using an inverted microscope 
(Leica DMI6000 B) equipped with a motorized focus and stage. 
Cell migration was followed for 22.5 hours using the manual 
tracking plugin in ImageJ. For proliferation and spreading assays, 65 
after cell fixation, cells were stained for nuclei as well as F-actin 
and Z-stack images (total stack size: 500 µm) were acquired at 10 
x magnification using a confocal microscope (Leica TCS SP5). 
Cell proliferation was analyzed by measuring the numbers of 3D 
F-actin using the ImageJ plugin ‘Object Counter3D’. For 70 
circularity ratio, a Z-stack projection from F-actin Z-stack images 
(total stack size: 150 µm) was made and cell circularity ratio was 
calculated using ImageJ. Cell circularity ratio is the ratio between 
a cell’s shape and a circle with the same perimeter. It therefore is 
a dimensionless number that is greater than 0 and less or equal to 75 
1. The more elongated a cell is the closer the circularity ratio is to 
0. Cells with a circularity ratio below 0.25 were considered as 
elongated. 
 
Preparation of the PDMS frames 80 
Polydimethylsiloxane (PDMS) frames were made as described 
previously.16 In short, the silicon elastomer and the curing agent 
(Sylgard 184, Dow Corning Corporation, USA) were mixed (10:1 
in mass) at 2000 rpm for 3 min in a ARE-250 mixer (Thinky 
Corporation, Japan). The mixture was subsequently poured into 85 
poly(methyl methacrylate) (PMMA) molds, where 500 µm in 
diameter stainless steel wires were positioned to create the holes 
for the future electrodes. The mixture was subsequently degassed 
for 30 min in a vacuum chamber and baked for 4 h at 60°C. The 
stainless steel wires and the PDMS forms were removed from the 90 
PMMA molds, rinsed with isopropanol (IPA), oxygen plasma 
cleaned (1 min at 300 W, Plasma-System 100, Technics Plasma 
GmbH, Germany) and finally pressed onto plasma cleaned 
microscope glass cover slips. Straightened Tungsten wires (W, 
500 µm in diameter, Advent Research Materials Ltd, UK) were 95 
inserted in the PDMS forms and connected to a potentio-
galvanostat in a two electrode setup (PGU-10V-1A-IMP-S and 
ECMwin computer interface, Elektroniklabor Peter Schrems, 
Germany). 
 100 
Recombinant Proteins 
Untagged growth factors were purchased from Peprotech 
(VEGF121, cat. no. 100-20A; PDGF-BB, cat. no. 100-14B). 
Linker protein Gln-ZZ was recombinantly produced in E.coli 
Bl21 as described previously.25 Fc tagged PDGF-BB (PDGF-105 
BBFc) and VEGF-A (VEGF-AFc) were cloned, expressed and 
purified as follows: PDGF-B and VEGF-A from Homo sapiens 
(PDGF-B: NP_002599.1, aa: 21-190 and VEGF-A: 
NP_001020539.2, aa: 207-371) were cloned into a modified 
PCEP vector with an N-terminal double Strep- tag II fused 110 
followed by Igh protein from Mus musculus (AAH03435.1, aa: 
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245-463). A pool of HEK293 cells were stably transfected 
followed by screening for high level expression. Secreted PDGF-
BBFc and VEGF-AFc were purified by Streptavidin beads (IBA). 
The purified PDGF-BBFc and VEGF-AFc were then dialyzed 
against 1 x phosphate buffer saline (PBS) pH 7.4. Labeling of 5 
PDGF-BBFC was done using DyLight 550 Fluorophore (Thermo 
Fisher Scientific Inc.) following the manufacturer’s instructions. 
 
Solid Phase Binding Assay between Gln-ZZ and PDGF-BBFc 
Gln-ZZ peptide was coated at 10 µg ml-1 (500 ng well-1) 10 
overnight at 4°C onto 96-well plates (Nunc Maxisorb). After 
washing with TBS, plates were blocked for 2 hours at RT with 
TBS containing 3% bovine serum albumin. Ligand (PDGF-BBFc) 
was diluted to concentrations from 0.03 nM to 500 nM and 
incubated for 2 hours at room temperature. After extensive 15 
washing with TBS, bound ligands were detected with a 
streptavidin horseradish peroxidase (HRP)-conjugate (IBA) 
1:5000. HRP was detected by Pierce TMB ELISA Substrate 
(Thermo Scientific™). Absorption was measured at 450 nm after 
stopping the reaction with 2 M sulfuric acid. A Blank value 20 
corresponding to BSA coated wells was automatically subtracted. 
 
Channel and PDGF gradient formation in TG-PEG hydrogels 
Perfusable channels with a diameter of 500 µm were produced in 
TG-PEG hydrogels as described previously.16 Briefly, 60 µl of 25 
complete TG-PEG hydrogel mixture, if indicated, containing 
MSCs were poured before the onset of gelation into the PDMS 
frame accommodating a straightened Tungsten wire. The 
polymerization of the TG-PEG was allowed to progress during 6 
minutes while the Tungsten wire was anodically polarized (2 V 30 
DC, versus a Platinum auxiliary electrode). Subsequent removal 
of the anodically polarized Tungsten wires lead to reproducible 
formation of regularly shaped channels within the TG-PEG gel. 
Stable or evolving PDGF gradients were formed by perfusing the 
channel with 1 µl PDGF-Fc or fluorescently labeled PDGF-Fc 35 
(180 ng µl-1) in presence or absence of 20 µM Gln-ZZ in the 
surrounding TG-PEG gel, respectively. Images of fluorescently 
labeled PDGF-BBFc gradients were taken after 0.5, 24, and 48 
hours using an inverted fluorescence microscope (Leica 
DMI6000 B). Fluorescence intensity was measured on a line 40 
perpendicular to the channel using the PlotProfile function in 
ImageJ 
 
Analysis of MSC spreading and migration within PDGF-BB 
gradients 45 
MSCs were encapsulated in TG-PEG hydrogels (final conc.: 0.5 
x 106 ml-1) within the PDMS mold and cultured overnight. The 
day after, Tungsten wires were removed and indicated amounts of 
PDGF-BBFc were loaded into the channel. For migration assays, 
two positions adjacent to the channel and two positions 3 mm 50 
away from the channel were selected using an inverted 
microscope (Leica DMI6000 B) equipped with a motorized focus 
and stage. Cell migration was followed for 22.5 hours using the 
manual tracking plugin in ImageJ. For spreading analysis, cells 
were fixed after 48 hours in culture. After F-actin staining, Z-55 
stack images (total stack size: 150 µm) of the complete constructs 
were acquired at 10 x magnification using a confocal microscope 
(Leica SP5) equipped with a long distance 10 x objective. Z-stack 
projections were made thereof, stitched together and the image 
was divided into 8 equally sized segments each having a width of 60 
0.5 mm. For quantification, cell circularity ratio was analyzed in 
each part using ImageJ. 
 
Statistical Analysis 
All mean values were compared by one-way analysis of variance 65 
(ANOVA) using MATLAB (R2013a, MathWorks Inc, USA) 
followed by a tukey-kramer post hoc test to judge statistical 
significance. Statistical significance was accepted for p < 0.05. 
One asterisks reports p < 0.05 and two asterisks p < 0.01. 
Results 70 
PDGF-BB modulates 3D MSC functions in vitro 
In order to study the role of PDGF-BB on MSC during 
morphogenesis in the perivascular space, we established a 3D 
microtissue-based in vitro assay. 
MSC microtissues were embedded within a recently developed 75 
polyethylene glycol (PEG) hydrogel, termed ‘TG-PEG hydrogel’, 
that recapitulates biochemical and biophysical properties of the 
microenvironment MSCs face in their anatomical location.12, 13 
This synthetic hydrogel was formulated to be matrix MMP-1-
degradable, have low cross-link density (94 ± 25 Pa shear 80 
modulus)14 and provide cell adhesion sites (50 µM RGD) in order 
to provide the MSCs a hydrated microenvironment in which 
proliferation, spreading and migration are possible. 4 hours after 
stimulation of the MSC microtissues with PDGF-BB already, 
MSCs started to migrate from the microtissues into the 85 
surrounding synthetic environment. Quantification of migration 
showed that in absence of PDGF-BB cells remained in a 
quiescent state within the microtissue, whereas upon 20 hours of 
exposure to PDGF-BB (10 nM) cells had invaded the artificial 
ECM up to 500 µm (Fig. 2A and 2B). When MSC microtissues 90 
were treated with equal amounts of VEGF121 no significant 
outgrowth was observed as compared to the controls. Taken 
together, this data confirmed that PDGF-BB specifically controls 
morphogenesis related functions of MSCs and that its role can be 
studied in vitro within the designed artificial environment.  95 
 
Discrimination of 3D morphogenetic processes by single cell 
assay 
To elucidate the effect of PDGF-BB on individual cellular 
processes, single dispersed cells were embedded in TG-PEG 100 
hydrogels and cultured for several days in the absence or in the 
presence of 10 and 50 nM PDGF-BB. Confocal images (z-stacks) 
of cytoskeleton stained cells after 5 days of culture revealed that 
presence of PDGF-BB had a dose dependent effect, which 
resulted in the formation of relatively dense cellular networks 105 
(Fig. 3A). Automated quantification of confocal images was 
applied to analyze cell number, cell circularity ratio as a measure 
of cell elongation, and single cell migration. PDGF-BB enhanced 
MSC numbers on average by 45% (10 nM PDGF-BB) and 81% 
(50 nM PDGF-BB) (Fig. 3B). Moreover, MSC Population’s cell 110 
elongation was shifted towards more spread cells with a smaller 
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cell circularity ratio after treatment with PDGF-BB (Fig. 3C). 
Based on the evaluation of the cell populations’ circularity ratio 
histograms, a cell that had a circularity ratio below 0.25 was 
considered as elongated. In the untreated cell population only 13 
± 4% of the cells were elongated whereas in the PDGF-BB 5 
treated conditions 32 ± 9% (10 nM PDGF-BB) and 63 ± 5% (50 
nM PDGF-BB) of the cells were elongated (Fig. 3D). Also, cell 
motility was increased in a dose dependent manner as found by 
tracking cells for 22.5 hours (Fig. 3E). Whereas the mean 
distance that cells migrated during this time in the control sample 10 
was 47 ± 11 µm, cells that were exposed to 10 nM or 50 nM 
PDGF-BB migrated 173 ± 20 µm or 246 ± 14 µm, respectively. 
Taken together, this data indicates that PDGF-BB is an important 
player in influencing multiple facets of MSC morphogenesis. 
 15 
Matrix-mediated presentation of PDGF-BB 
In order to mimic the naturally occurring interactions between 
heparin sulphates of the ECM and PDGF-BB and to control the 
spatiotemporal distribution of PDGF-BB within the in vitro niche 
model, the fragment crystallisable (Fc) region of antibodies was 20 
added to the N-terminus of PDGF-BB. This new variant (PDGF-
BBFc) enables its high-affinity immobilization in TG-PEG 
hydrogels provided that during hydrogel formation a recently 
developed bifunctional linker protein (GlnZZ)15 was incorporated 
in the TG-PEG backbone. Gln-ZZ can be incorporated into the 25 
TG-PEG hydrogel backbone via its C-terminal domain (Gln) and 
has high affinity for Fc-tagged proteins through its N-terminal Z 
domains. Specific binding of the PDGF-BBFc fusion protein to 
Gln-ZZ was confirmed by a solid-phase binding assay (Fig. 
S1A). To test the biological activity of PDGF-BBFc microtissues 30 
were embedded in TG-PEG gels and cultivated in medium 
containing 10 or 50 nM soluble PDGF-BBFc (no Gln-ZZ linker). 
Figures S1A and S1B show cell migration distance and attest 
bioactivity of the engineered Fc-tagged protein. 
 35 
As for testing the activity of bound PDGF-BBFc, microtissues 
were embedded in TG-PEG gels containing 20µM Gln-ZZ 
incorporated in the hydrogel backbone. These microtissues were 
exposed to admixed 0, 10 and 50nM PDGF-BBFc. The excess of 
Gln-ZZ over PDGF-BBFc assures that the majority of PDGF-BBFc 40 
molecules are present in their matrix immobilized form. In the 
absence of growth factors, MSCs fully remained in the 
microtissue, with as little as 3% of actin stained areas (pixels) 
belonging to cells that had left the microtissue (Fig. 4) . On the 
other hand, cells that were exposed to hydrogels containing 10 45 
and 50nM PDGF-BBFc displayed clear morphogenesis related 
functions with respectively 41% and 67% of actin stained pixels 
detached from the microtissue (Fig. 4). This significant difference 
indicates that MSC activity can be modulated in a dose dependent 
manner. In addition, the data suggests that PDGF-BBFc 50 
immobilization does not significantly alter its activity. This is 
shown by the similar morphogenetic activity observed between 
10 nM immobilized (20 µM Gln-ZZ) and free diffusing (0 µM 
Gln-ZZ) PDGF-BBFc in Fig. 4A. 
Fig. 2 PDGF-BB induces 3D MSC morphogenesis in biomimetic microenvironment. MSC microtissues consisting of approx. 750 cells were embedded in 
synthetic matrices and stimulated with the indicated growth factor for 20 hours under serum-free conditions. A) Z-stack projections of F-actin stained 
MSCs (upper panels, scale bar = 200 µm). Histograms showing the distribution of MSCs from microtissue center when stimulated with the respective
growth factor (lower panels). B) Bar graph illustrating the percentage of actin-stained pixels being located at a distance larger than 100 µm from the centre 
of the microtissue. Data is depicted as mean ± SD (n ≥ 4, **, p < 0.01, n.s., not significant). 
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Microfluidic approach for the creation of 3D PDGF-BB 
gradients in TG-PEG hydrogels 
 
As opposed to traditional cell culture assays, biomolecules within 
the body are not present in uniform concentrations, but rather in 5 
concentration gradients that descend from the site of biomolecule 
expression.21 In order to mimic in vitro the 3D PDGF-BB 
gradient that occurs in the perivascular niche around blood 
vessels, we applied a recently developed electrochemistry-based 
technique to form artificial vessels in the middle of the hydrogel 10 
by spatially inhibiting hydrogel polymerization.16 Such channels 
were loaded with controlled amounts of PDGF-BBFc, which 
could freely diffuse from the channel into the surrounding 
hydrogel and reach the MSCs (Fig. 5A). To monitor PDGF-BB 
diffusion into MSC containing hydrogels, fluorescently labeled 15 
PDGF-BBFc was loaded in a channel and its distribution in the gel 
was analysed (Fig. S2). After 48 hours the PDGF-BBFc gradient 
had leveled out and PDGF-BBFc was almost homogenously 
distributed within the hydrogel (Fig. 5B). In order to fabricate a 
more sophisticated model that takes into account the interaction 20 
of PDGF-BB with the ECM, we made channels in Gln-ZZ 
containing hydrogels. 
To test if the before described interaction between PDGF-BBFc 
and Gln-ZZ would indeed lead to the establishment of the graded 
3D immobilization of PDGF-BB, we perfused the fluorescently 25 
labeled PDGF-BBFc through the channel into the Gln-ZZ 
presenting and MSC containing hydrogel (Fig. 5C). 48 hours 
after perfusion, a stable 3D PDGF-BBFc gradient originated from 
the channel into the hydrogel, indicating a stable interaction 
between PDGF-BBFc and the matrix in presence of MSCs (Fig. 30 
5D). 1.5 mm from the channel the level of fluorescently labelled 
PDGF-BBFc had decreased to background level.  
 
Fig. 3 PDGF-BB induces proliferation, spreading and migration of 3D encapsulated MSCs. MSCs were encapsulated in TG-PEG hydrogels (0.5 * 106 cells 
ml-1) and cultured under serum-free conditions in presence of the indicate amounts of PDGF-BB A) Z-stack projections (total stack size 500 µm) of F-actin 
stained MSCs after 5 days of culture (scale bar = 200 µm). B) MSC numbers as analysed by counting connected F-actin objects in 3D by an automated 
image analysis script as described in materials and methods. C) Histogram depicting the MSC population’s circularity ratio (4π*(cell area)/(cell 
perimeter^2)). D) Bar graph depicting percentage of elongated cells. Cells with a circularity ratio below 0.25 were considered as elongated. E) Cell tracks 
of MSCs were acquired and overlaid with a common starting point. The tracks represent a period of 22.5 hours (18 x 75 min) starting 24 hours after first 
growth factor exposure. F) Bar graph depicting mean migration distance. Data is depicted as mean ± SD (n ≥ 4, *, p < 0.05, **, p < 0.01, n.s., not 
significant). 
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MSC morphogenesis in evolving versus stable 3D PDGF-BB 
gradients 
In order to elucidate MSCs’ morphogenetic response to being 
exposed to evolving and stable gradients of PDGF-BBFc, MSCs 
were encapsulated in TG-PEG hydrogels containing an artificial 5 
vessel for biomolecule perfusion. As expected, perfusion of the 
channel with control medium without PDGF-BBFc did not lead to 
a morphogenetic response as shown by measuring the cellular 
circularity ratio two days after perfusion within 3 consecutive 
segments each spanning 1.5 mm (Figure S3). Percentage of cells 10 
that were elongated (circularity ratio < 0.25) remained around 
10% in all segments. This coincides with the value that was 
previously observed for the control in the static condition (Fig. 
3C and 3D).  On the other hand, perfusion of 4 µM PDGF-BBFc, 
which created a short-term-evolving gradient of PDGF-BBFc as 15 
shown before (Fig. 5B), lead to cell spreading (decrease in 
circularity ratio) similarly to the previous static experiments (Fig. 
3C and D). After 2 days, however, only minor spatial differences 
in cell spreading were observed due to the levelling out of the 
soluble PDGF-BBFc concentrations throughout the sample (Fig. 20 
6A). Percentage of cells that were elongated (circularity ratio < 
0.25) was roughly between 20% and 40% (Figure 6C), which 
correlated with the elongation that was seen in the static condition 
in presence of 10 nM PDGF-BB (Fig. 3C and 3D). 
 25 
In contrast, if a stable PDGF-BB gradient was formed by 
perfusion of Gln-ZZ (20 µM) modified TG-PEG hydrogels with 4 
µM PDGF-BBFc the morphogenetic response of encapsulated 
MSCs was locally restricted to the vicinity (0 - 1500 µm) of the 
artificial vessel (Fig. 6B). Due to the stable retention of PDGF-30 
BBFc only in the first segment 20% of the cells were elongated 
(circularity ratio < 0.25) whereas cells further away were not 
affected by the growth factor presence (Fig. 6C). Moreover, the 
bound growth factor was locally inducing MSC motility as shown 
by the cell tracks of cells at 0 - 1 mm versus 2.5 – 3.5 mm 35 
distance from the channel (Fig. 6B). These results emphasize the 
role of biomolecules within complex in vitro models and even 
more so the importance of controlling them spatiotemporally by 
mimicking the processes occurring in nature. 
 40 
Fig. 4 MSC migration in synthetic PDGF-BBFc-presenting cell-instructive matrices. MSC microtissues consisting of approx. 750 cells were encapsulated 
in TG-PEG hydrogels containing 0  µM (black) or 20 µM (grey) Gln-ZZ and 0, 10, or 50nM PDGF-BBFc. A) Representative CLSM Z-stack projections of 
F-actin stained MSCs cultured for 20 hours under serum-free conditions (upper panels, cale bar = 200 µm). Histograms showing the distribution of MSCs 
from microtissue center when embedded within the indicated matrix (lower panels). B) Bar graph shows the percentage of actin-stained pixels being 
located at a distance larger than 100 µm from the centre of the microtissue. Data is depicted as mean ± SD (n ≥ 3, **, p < 0.01). 
Fig. 5 Hydrogel microfluidics for creation of evolving and stable PDGF-
BB gradients in presence of cells. Scheme of PDGF-BBFc delivery to 3D 
encapsulated MSCs using a perfusable channel in standard (A) and Gln-
ZZ modified (C) TG-PEG hydrogels. Hydrogel channels were formed by 
electrochemical inhibition of hydrogel polymerization as described 
previously.16 B and D) Fluorescent microscopy images showing the area 
around the respective hydrogel channels 48 hours after perfusion with 
DyLight 550-labeled PDGF-BBFc (upper panel) and the corresponding 
grey value plots. 
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Discussion 
A prevalent limitation to 2D and 3D cell culture assays has long 
been the lack of spatial and temporal control over the presentation 
of biomolecules, which especially for the engineering of complex 
milieus such as the stem cell niche is an evident prerequisite. We 5 
here present a biomimetic approach that recapitulates the 
localized ECM immobilization of PDGF-BB in the perivascular 
niche. By combining an electrochemistry-based hydrogel 
patterning approach16 with engineering of growth factor matrix 
interactions and diffusion controlled establishment of 3D 10 
gradients, human MSCs can readily be exposed to selected micro-
environmental conditions as would be expected to occur in the 
surrounding of a blood vessel. This experimental setup offers 
several advantages to existing models: i) it is based on engineered 
ECM with defined and tunable physical, chemical and biological 15 
properties ii) growth factors can be promiscuously immobilized 
via affinity interactions and thus can be loaded independently of 
hydrogel formation and cell encapsulation iii) the use of channels  
 allows the sequential loading of multiple engineered and native 
growth factors iv) due to the transparent character of the hydrogel 20 
system, cell behavior can be monitored throughout the length of 
the experiment so that morphogenetic parameters can be followed 
and independently evaluated.  
Despite the fact that great efforts were devoted towards the 
development of models for studying cell fates in stable growth 25 
factor gradients in vitro, described approaches either do not take 
into account the three dimensionality of the microenvironment 
that surrounds cells in vivo22-26 or employ matrices with inherent 
biological  properties27-29.  
 To the best of our knowledge, this is the first report on the 30 
implementation of a stable growth factor gradient within a fully 
defined synthetic hydrogel matrix. Moreover, as opposed to other 
studies27-29 that show stable 3D growth factor gradients, we here 
describe a method that allows for gradient formation in presence 
of cells, which is not only more closely mimicking the situation 35 
in nature, but as well omitting material interface problems that 
result from pre-fabrication of the gradient and post-hoc seeding 
of the cells onto the gradient. 
VEGFs and PDGFs are known to be jointly involved in the 
assembly and stabilization of new vessels5. This was illustrated 40 
by the elimination of either VEGF signaling in endothelial cell or 
PDGF signaling in pericytes or by the deletion of either the 
ligands or the receptors, which has resulted in a largely defective 
development and function of vessels, leading to embryonic 
lethality.30-33 In vitro PDGFs promote the migration of multiple 45 
mesenchymal cell types such as fibroblasts, smooth muscle cells, 
and MSCs. However their role in controlling cell behavior during 
Fig. 6 Evaluation of MSCs in a model of the perivascular niche microenvironment mimicking evolving and stable PDGF-BB gradients. MSCs were 
encapsulated (0.25 * 106 cells ml-1) in TG-PEG hydrogels and channels for biomolecule perfusion were formed by electrochemical inhibition of hydrogel 
polymerization. Data is shown for both conditions after 48 hours of culture as representative Z-stack images (total stack size 500 µm) of F-actin stained 
MSCs (Scale bar = 500 µm). Channels in unaltered (A) and 20 µM Gln-ZZ containing (B) TG-PEG hydrogels were perfused with 4 µM PDGF-BBFc. 
Inlays display overlaid tracks of migrating MSCs at the indicated positions of the sample. The tracks represent a period of 22.5 hours (18 x 75 min) 
starting 24 hours after PDGF-BBFc perfusion. C) Histogram depicting percentage of cells with a circularity ratio below 0.25 relative to distance to channel 
in gels with 0 µM (black) or 20 µM Gln-ZZ (grey). Statistical comparison is made between the two groups of each region. Data is depicted as mean ± SD 
(n ≥ 4, n.s., not significant, **, p < 0.01). 
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vessel stabilization has not been characterized in detail. As 
opposed to other studies,34 we demonstrate the specific in vitro 
induction of morphogenetic processes in hydrogel encapsulated 
MSC microtissues by soluble PDGF-BB but not VEGF.  
Importantly, the majority of expressed VEGF and PDGF 5 
molecules contain a positively charged C-terminal domain, which 
has been described to bind HSPGs of the extracellular matrix.35 
In vivo this affinity of growth factors to the ECM limits their 
diffusion away from the site of production and likely results in 
the formation of relatively stable positional cues. The 10 
consequence of such ECM immobilized cues for the formation of 
functional, properly structured vascular networks has been 
impressively shown by transgenic mice which either express only 
VEGF-variants that lack the C-terminal heparin binding domain 
(VEGF121) or only have high affinity for heparin (VEGF189)
36, 37. 15 
While in the first case due to loss of directionality during 
branching, resulting vessels were large in diameter and less 
branched in the latter case extensive filopodia formation, highly 
branched and thin vessels were observed.38 Similarly, the deletion 
of the C-terminal heparin binding motif of PDGF-BB resulted in 20 
abnormal coverage of pericytes, and their partial detachment from 
the vessel wall which for example manifests in defective vessels 
and consequently in retinal deterioration, or proteinuria.3, 39 These 
data indicate a role for the ECM immobilization of PDGF-BB in 
the assembly of functional blood vessels. The C-terminal binding 25 
motif of PDGFs largely restricts its distribution and availability in 
vivo near to the site of productions, which in the case of vessels is 
in the perivascular zone.3 In the presented in vitro model, a 
synthetic protein linker was applied to mimic this natural PDGF-
BB ECM interaction. Additionally, fabrication of a perfusable 30 
channel in the hydrogel allowed for controlling the PDGF-BB 
source and thereby creation of evolving as well as, in the case of 
matrix-interacting PDGF-BB, stable 3D PDGF-BB gradients. 
Stable PDGF-BB gradients restricted PDGF-BB-induced 
spreading and migration to the vicinity of the growth factor 35 
source. In contrast, the freely diffusible growth factor led to a 
transient gradient rapidly leveling out throughout the gel. Similar 
observations were made by Nguyen et al.,40 who recently 
described that a gradient formed in a hydrogel from a channel, 
initially spans over 300 µm and covers over 900 µm after 1h 40 
only. This short-term gradient of the growth factor lead to 
homogenous biological response throughout the entire model. 
These data indicate that the native perivascular organization of 
cells can be recapitulated in vitro by appropriate presentation of 
PDGF gradients. In 2D setups, soluble PDGF gradients were 45 
shown to induce fibroblast polarization and chemotaxis.41, 42 
However, in the herein presented 3D setup, both soluble PDGF 
and the gradient of matrix-immobilized PDGF stimulated a 
chemokinesis related (stochastic) migration process. From these 
experiments it remains unclear whether during the formation of 50 
the gradient a short-term exposure of the MSCs to soluble PDGF, 
residual non-bound PDGF, or trace amounts of released PDGF 
were sufficient to induce non-directed migration or whether 
PDGF generally induces a migration process resembling 
chemokinesis. The high binding affinity of the ZZ-tag to Fc-55 
domains (Kd = 4.8 * 10-8 M-1)43 would suggest, that the release of 
the growth factor would be mainly be due to the very slow (not 
yet carefully characterized) degradation of the PEG-based matrix 
by cell-mediated cleavage of built-in MMP-sensitive linker 
sequences14, 44. This indicates that although MSC migration might 60 
not occur in a highly directional fashion the sum of the PDGF-
mediated processes leads to the assembly and stabilization of a 
perivascular niche. A further limitation of the current study is that 
in this simplified model the direct contact of MSCs with the 
vascular basement membrane, which is a known regulator of 65 
various stem cells, is not reproduced45, 46. Together, these 
observations indicate that our in vitro model recapitulates some 
of the dynamics that are assumed to be present during vessel 
formation, including the diffusion of trace amounts of PDGF 
from the site of production before the capturing by the 70 
glycosaminoglycan components of the ECM. Enzymatic 
remodeling of the ECM by mobilized cells is also represented by 
the slow MMP-dependent degradation of the PEG-matrix and the 
consequent release of PDGF. 
The steepness of the gradient and the protease-mediated release 75 
of PDGF from gradients can have a large influence on the amount 
of factor seen by a cell. As in this study these parameters were 
kept constant we cannot exclude that chemotactic migration 
would preferentially occur in steeper gradients or upon cell-
mediated promotion of release. Based on the observed slow 80 
degradability and thus the low availability for cells under 
evaluated cell culture conditions it is tempting to speculate that 
the graded PDGF reservoir is only very slowly exploited during 
the observed culture period. Both faster release kinetics and 
longer observations could thus clearly reinforce MSC function 85 
and even lead to improved tissue morphogenesis. 
This study was restricted to the description of the isolated 
mesenchymal compartment of the perivascular niche. Earlier in 
vitro studies have described models, which use both 
mesenchymal, and endothelial cells to create a perivascular 90 
niche47, 48. One approach which integrated microfluidic channels 
and 3D fibrin encapsulation of endothelial cells and MSCs 
revealed an important function of laminin to control the 
perivascular location of MSCs in an α6β1 integrin mediated 
manner48. This finding correlates well with studies showing the 95 
perivascular location of neuronal stem cells46, 49 and the critical 
function of vascular basal membrane laminin to control MSC 
function by α6β1 integrin and PDGF-BB signaling
48, 50. The 
integration of endothelial cells with herein described perivascular 
niche model consisting of MSCs which are exposed to stable 100 
growth factor gradients might provide a promising platform for 
the studying of stem cells in their perivascular niche while 
varying individual cellular, matrix associated or soluble bio-
molecular factors. 
Conclusions 105 
By combining advanced biomaterials with microfluidic 
technology we here present the creation of a spatially-defined 
tissue model recapitulating mechanical properties and stable 
PDGF gradients of the perivascular niche. We believe that this 
model and its further development by the incorporation of 110 
endothelial cells will help increase our understanding of the role 
of MSCs in vascular function as well as the cell extrinsic cues 
that control their fate.  
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Graphical and Textual Abstract 
 
 
Towards the development of an in vitro perivascular niche: Locally controlling MSC 
morphogenetic processes by 3D PDGF-BB gradients 
P.S. Lienemann, Y. R. Devaud, R. Reuten, B.R. Simona, M. Karlsson, W. Weber, M. Koch, M.P. 
Lutolf, V. Milleret, and M. Ehrbar 
 
 
 
We report on the creation of a three dimensional biomimetic tissue model that recapitulates the stable 
PDGF-BB gradient controlling mesenchymal stem cell morphogenetic behavior in the perivascular 
niche. 
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